Announcement • Jun 03
Peptonic Medical AB Launches New Product Segment In Health And Beauty And Introduces New Brand Peptonic Medical AB (publ) is launching a new product segment within health and beauty. This initiative represents a significant broadening of the Company's product portfolio and constitutes an important step in the long-term strategy to create new revenue streams and strengthen the market position. The launch is planned for the second half of 2026. In connection with this, the Company will also bring products together under a new common brand in accordance with the strategic development plan. The first product will be an innovative dietary supplement developed as part of Peptonic Medical's long-term strategy to broaden its offering within women's health and beauty. As part of strengthening and complementing the product portfolio, the Company has also expanded the range with two new products ahead of upcoming launches: intimate wipes and a moisturising intimate cream. The dietary supplement is a functional beauty blend powder that combines collagen peptides with carefully selected vitamins, minerals and active ingredients. The formula is designed to support skin structure, hair and nails, as well as contribute to energy and general well-being. The product contains, among other things, vitamin C, which contributes to normal collagen formation; biotin and zinc, which help maintain normal hair, skin and nails; hyaluronic acid for skin hydration; and red maca - a plant-based ingredient traditionally associated with hormonal balance. By addressing needs that arise during different hormonal phases, the product has been developed as a daily dietary supplement for women throughout their hormonal journey. The launch also strengthens the Company's position with a new brand and a broader target audience. The launch represents a further step in the Company's long-term ambition to develop innovative products with a focus on wellbeing, quality of life and beauty. Reported Earnings • May 28
First quarter 2026 earnings released First quarter 2026 results: Revenue: kr3.40m (down 9.6% from 1Q 2025). Net loss: kr5.68m (loss narrowed 24% from 1Q 2025). Announcement • May 21
Peptonic Medical AB Launches VagiVital Intimate V Wipes Peptonic Medical AB (publ) announced expanding its product portfolio in the intimate health category and launching VagiVital Intimate V Wipes, intimate wipes specially developed for gentle cleansing of the external areas of the intimate region. The launch is part of Peptonic's strategy to develop VagiVital into a stronger and broader brand in intimate care, with products for a variety of everyday needs. The launch is a strategically important step in Peptonic's ambition to develop VagiVital into a leading, comprehensive brand in intimate self-care, with products that meet women's needs throughout all stages and situations of life. With VagiVital Intimate V Wipes, Peptonic is expanding its offering from treatment and moisturizing products to include practical premium products for daily intimate care and an active lifestyle. VagiVital Intimate V Wipes are exclusively developed for external intimate care and contain glycerin to moisturize the skin, as well as a pre- and probiotic complex that helps support the skin's natural balance. The product leaves the skin clean, fresh, and soft while contributing to a pleasant sense of comfort and well-being. The launch strengthens Peptonic's position in modern intimate self-care and is a step toward making intimate care more accessible, less stigmatized, and integrated into women's daily lives. Intimate V Wipes are scheduled to launch in the second half of 2026. 
